Title: Quantitative proteomics to study carbapenem resistance in Acinetobacter baumannii

Frontiers in Microbiology

Volumn 5, Issue SEP, 2014, Pages

  Tiwari, Vishvanath ^a   Tiwari, Monalisa ^a  

^a CENTRAL UNIVERSITY OF RAJASTHAN   (India)

Author keywords

Acinetobacter baumannii; Biofilm formation; Carbapenem resistance; Pathogenesis; Quantitiave proteomics

Indexed keywords

ABC TRANSPORTER; CARBAPENEM; CHAPERONE; ELONGATION FACTOR; IMIPENEM; IRON BINDING PROTEIN; OUTER MEMBRANE PROTEIN; OUTER MEMBRANE PROTEIN A; PENICILLIN BINDING PROTEIN; RIBOSOME PROTEIN;

ACINETOBACTER BAUMANNII; ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL STRAIN; BIOFILM; DESICCATION; DRUG RESPONSE; ISOELECTRIC POINT; LIPOGENESIS; MASS SPECTROMETRY; NONHUMAN; PNEUMONIA; POLYACRYLAMIDE GEL ELECTROPHORESIS; PROTEIN EXPRESSION; PROTEOMICS; REPRODUCIBILITY; RESPIRATORY TRACT INFECTION; REVERSED PHASE LIQUID CHROMATOGRAPHY; URINARY TRACT INFECTION;

ACINETOBACTER BAUMANNII;

EID: 84949116813     PISSN: None     EISSN: 1664302X     Source Type: Journal    
DOI: 10.3389/fmicb.2014.00512     Document Type: Article

References (69)

1. Abdallah, C., Dumas-Gaudot, E., Renaut, J., and Sergeant, K. (2012). Gel-based and gel-free quantitative proteomics approaches at a glance. Int J Plant Genomics 2012, 494572. doi: 10.1155/2012/494572.
2. Bergogne-Berezin, E., and Towner, K.J. (1996). Acinetobacter spp. as nosocomial pathogens: microbiological, clinical, and epidemiological features. Clin Microbiol Rev 9, 148-165.
3. Bonin, R.F., Chapeaurouge, A., Perales, J., Da Silva Junior, J.G., Do Nascimento, H.J., D'alincourt Carvalho Assef, A.P., and Senna, J.P. (2014). Identification of immunogenic proteins of the bacterium Acinetobacter baumannii using a proteomic approach. Proteomics Clin Appl. doi: 10.1002/prca.201300133.
4. Boucher, H.W., Talbot, G.H., Bradley, J.S., Edwards, J.E., Gilbert, D., Rice, L.B., Scheld, M., Spellberg, B., and Bartlett, J. (2009). Bad bugs, no drugs: no ESKAPE! An update from the Infectious Diseases Society of America. Clin Infect Dis 48, 1-12. doi: 10.1086/595011.
5. Cabral, M.P., Soares, N.C., Aranda, J., Parreira, J.R., Rumbo, C., Poza, M., Valle, J., Calamia, V., Lasa, I., and Bou, G. (2011). Proteomic and functional analyses reveal a unique lifestyle for Acinetobacter baumannii biofilms and a key role for histidine metabolism. J Proteome Res 10, 3399-3417. doi: 10.1021/pr101299j.
6. Chen, Y.T., Chen, C.L., Chen, H.W., Chung, T., Wu, C.C., Chen, C.D., Hsu, C.W., Chen, M.C., Tsui, K.H., Chang, P.L., Chang, Y.S., and Yu, J.S. (2010). Discovery of novel bladder cancer biomarkers by comparative urine proteomics using iTRAQ technology. J Proteome Res 9, 5803-5815. doi: 10.1021/pr100576x.
7. Choi, Y.E., and Shim, W.B. (2008). Identification of genes associated with fumonisin biosynthesis in Fusarium verticillioides via proteomics and quantitative real-time PCR. J Microbiol Biotechnol 18, 648-657.
8. Davis, K.A., Moran, K.A., Mcallister, C.K., and Gray, P.J. (2005). Multidrug-resistant Acinetobacter extremity infections in soldiers. Emerg Infect Dis 11, 1218-1224. doi: 10.3201/eid1108.050103.
9. Desouza, L.V., Romaschin, A.D., Colgan, T.J., and Siu, K.W. (2009). Absolute quantification of potential cancer markers in clinical tissue homogenates using multiple reaction monitoring on a hybrid triple quadrupole/linear ion trap tandem mass spectrometer. Anal Chem 81, 3462-3470. doi: 10.1021/ac802726a.
10. Elliott, M.H., Smith, D.S., Parker, C.E., and Borchers, C. (2009). Current trends in quantitative proteomics. J Mass Spectrom 44, 1637-1660. doi: 10.1002/jms.1692.
11. Elschenbroich, S., and Kislinger, T. (2011). Targeted proteomics by selected reaction monitoring mass spectrometry: applications to systems biology and biomarker discovery. Mol Biosyst 7, 292-303. doi: 10.1039/c0mb00159g.
12. Espinal, P., Marti, S., and Vila, J. (2012). Effect of biofilm formation on the survival of Acinetobacter baumannii on dry surfaces. J Hosp Infect 80, 56-60. doi: 10.1016/j.jhin.2011.08.013.
13. Fiester, S.E., and Actis, L.A. (2013). Stress responses in the opportunistic pathogen Acinetobacter baumannii. Future Microbiol 8, 353-365. doi: 10.2217/fmb.12.150.
14. Gandhi, J.A., Ekhar, V.V., Asplund, M.B., Abdulkareem, A.F., Ahmadi, M., Coelho, C., and Martinez, L.R. (2014). Alcohol enhances Acinetobacter baumannii-associated pneumonia and systemic dissemination by impairing neutrophil antimicrobial activity in a murine model of infection. PLoS One 9, e95707. doi: 10.1371/journal.pone.0095707.
15. Gurung, J., Khyriem, A.B., Banik, A., Lyngdoh, W.V., Choudhury, B., and Bhattacharyya, P. (2013). Association of biofilm production with multidrug resistance among clinical isolates of Acinetobacter baumannii and Pseudomonas aeruginosa from intensive care unit. Indian J Crit Care Med 17, 214-218. doi: 10.4103/0972-5229.118416.
16. Gygi, S.P., and Aebersold, R. (2000). Mass spectrometry and proteomics. Curr Opin Chem Biol 4, 489-494.
17. Gygi, S.P., Rist, B., Gerber, S.A., Turecek, F., Gelb, M.H., and Aebersold, R. (1999). Quantitative analysis of complex protein mixtures using isotope-coded affinity tags. Nat Biotechnol 17, 994-999. doi: 10.1038/13690.
18. Hawkey, P.M., and Jones, A.M. (2009). The changing epidemiology of resistance. J Antimicrob Chemother 64 Suppl 1, i3-10. doi: 10.1093/jac/dkp256.
19. Hossain, M., Kaleta, D.T., Robinson, E.W., Liu, T., Zhao, R., Page, J.S., Kelly, R.T., Moore, R.J., Tang, K., Camp, D.G., 2nd, Qian, W.J., and Smith, R.D. (2011). Enhanced sensitivity for selected reaction monitoring mass spectrometry-based targeted proteomics using a dual stage electrodynamic ion funnel interface. Mol Cell Proteomics 10, M000062-MCP000201. doi: 10.1074/mcp. M000062-MCP201.
20. Jamulitrat, S., Arunpan, P., and Phainuphong, P. (2009). Attributable mortality of imipenem-resistant nosocomial Acinetobacter baumannii bloodstream infection. J Med Assoc Thai 92, 413-419.
21. Jin, J.S., Kwon, S.O., Moon, D.C., Gurung, M., Lee, J.H., Kim, S.I., and Lee, J.C. (2011). Acinetobacter baumannii secretes cytotoxic outer membrane protein A via outer membrane vesicles. PLoS One 6, e17027. doi: 10.1371/journal.pone.0017027.
22. Kellermann, J. (2008). ICPL--isotope-coded protein label. Methods Mol Biol 424, 113-123. doi: 10.1007/978-1-60327-064-9_10.
23. Kellermann, J., and Lottspeich, F. (2012). Isotope-coded protein label. Methods Mol Biol 893, 143-153. doi: 10.1007/978-1-61779-885-6_11.
24. Kempf, M., Bakour, S., Flaudrops, C., Berrazeg, M., Brunel, J.M., Drissi, M., Mesli, E., Touati, A., and Rolain, J.M. (2012). Rapid detection of carbapenem resistance in Acinetobacter baumannii using matrix-assisted laser desorption ionization-time of flight mass spectrometry. PLoS One 7, e31676. doi: 10.1371/journal.pone.0031676.
25. Klevens, R.M., Edwards, J.R., Tenover, F.C., Mcdonald, L.C., Horan, T., Gaynes, R., and National Nosocomial Infections Surveillance, S. (2006). Changes in the epidemiology of methicillin-resistant Staphylococcus aureus in intensive care units in US hospitals, 1992-2003. Clin Infect Dis 42, 389-391. doi: 10.1086/499367.
26. Klose, J. (1975). Protein mapping by combined isoelectric focusing and electrophoresis of mouse tissues. A novel approach to testing for induced point mutations in mammals. Humangenetik 26, 231-243.
27. Knowles, M.R., Cervino, S., Skynner, H.A., Hunt, S.P., De Felipe, C., Salim, K., Meneses-Lorente, G., Mcallister, G., and Guest, P.C. (2003). Multiplex proteomic analysis by two-dimensional differential in-gel electrophoresis. Proteomics 3, 1162-1171. doi: 10.1002/pmic.200300437.
28. Kwon, S.O., Gho, Y.S., Lee, J.C., and Kim, S.I. (2009). Proteome analysis of outer membrane vesicles from a clinical Acinetobacter baumannii isolate. FEMS Microbiol Lett 297, 150-156. doi: 10.1111/j.1574-6968.2009.01669.x.
29. Lee, H.Y., Chen, C.L., Wang, S.B., Su, L.H., Chen, S.H., Liu, S.Y., Wu, T.L., Lin, T.Y., and Chiu, C.H. (2011). Imipenem heteroresistance induced by imipenem in multidrug-resistant Acinetobacter baumannii: mechanism and clinical implications. Int J Antimicrob Agents 37, 302-308. doi: 10.1016/j.ijantimicag.2010.12.015.
30. Longo, F., Vuotto, C., and Donelli, G. (2014). Biofilm formation in Acinetobacter baumannii. New Microbiol 37, 119-127.
31. Marti, S., Sanchez-Cespedes, J., Oliveira, E., Bellido, D., Giralt, E., and Vila, J. (2006). Proteomic analysis of a fraction enriched in cell envelope proteins of Acinetobacter baumannii. Proteomics 6 Suppl 1, S82-87. doi: 10.1002/pmic.200500323.
32. Mazzoli, R., Fattori, P., Lamberti, C., Giuffrida, M.G., Zapponi, M., Giunta, C., and Pessione, E. (2011). High isoelectric point sub-proteome analysis of Acinetobacter radioresistens S13 reveals envelope stress responses induced by aromatic compounds. Mol Biosyst 7, 598-607. doi: 10.1039/c0mb00112k.
33. Mcqueary, C.N., and Actis, L.A. (2011). Acinetobacter baumannii biofilms: variations among strains and correlations with other cell properties. J Microbiol 49, 243-250. doi: 10.1007/s12275-011-0343-7.
34. Meleady, P. (2011). 2D gel electrophoresis and mass spectrometry identification and analysis of proteins. Methods Mol Biol 784, 123-137. doi: 10.1007/978-1-61779-289-2_9.
35. Mendez, J.A., Soares, N.C., Mateos, J., Gayoso, C., Rumbo, C., Aranda, J., Tomas, M., and Bou, G. (2012). Extracellular proteome of a highly invasive multidrug-resistant clinical strain of Acinetobacter baumannii. J Proteome Res 11, 5678-5694. doi: 10.1021/pr300496c.
36. Mirza, S.P., and Olivier, M. (2008). Methods and approaches for the comprehensive characterization and quantification of cellular proteomes using mass spectrometry. Physiol Genomics 33, 3-11. doi: 10.1152/physiolgenomics.00292.2007.
37. Mortensen, B.L., and Skaar, E.P. (2012). Host-microbe interactions that shape the pathogenesis of Acinetobacter baumannii infection. Cell Microbiol 14, 1336-1344. doi: 10.1111/j.1462-5822.2012.01817.x.
38. Navon-Venezia, S., Ben-Ami, R., and Carmeli, Y. (2005). Update on Pseudomonas aeruginosa and Acinetobacter baumannii infections in the healthcare setting. Curr Opin Infect Dis 18, 306-313.
39. Nwugo, C.C., Gaddy, J.A., Zimbler, D.L., and Actis, L.A. (2011). Deciphering the iron response in Acinetobacter baumannii: A proteomics approach. J Proteomics 74, 44-58. doi: 10.1016/j.jprot.2010.07.010.
40. O'farrell, P.H. (1975). High resolution two-dimensional electrophoresis of proteins. J Biol Chem 250, 4007-4021.
41. Ong, S.E., Blagoev, B., Kratchmarova, I., Kristensen, D.B., Steen, H., Pandey, A., and Mann, M. (2002). Stable isotope labeling by amino acids in cell culture, SILAC, as a simple and accurate approach to expression proteomics. Mol Cell Proteomics 1, 376-386.
42. Ong, S.E., and Mann, M. (2005). Mass spectrometry-based proteomics turns quantitative. Nat Chem Biol 1, 252-262. doi: 10.1038/nchembio736.
43. Paul, D., Kumar, A., Gajbhiye, A., Santra, M.K., and Srikanth, R. (2013). Mass spectrometry-based proteomics in molecular diagnostics: discovery of cancer biomarkers using tissue culture. Biomed Res Int 2013, 783131. doi: 10.1155/2013/783131.
44. Perdomo, A.B., Ciccosanti, F., Iacono, O.L., Angeletti, C., Corazzari, M., Daniele, N., Testa, A., Pisa, R., Ippolito, G., Antonucci, G., Fimia, G.M., and Piacentini, M. (2012). Liver protein profiling in chronic hepatitis C: identification of potential predictive markers for interferon therapy outcome. J Proteome Res 11, 717-727. doi: 10.1021/pr2006445.
45. Rabilloud, T., and Lelong, C. (2011). Two-dimensional gel electrophoresis in proteomics: a tutorial. J Proteomics 74, 1829-1841. doi: 10.1016/j.jprot.2011.05.040.
46. Ross, P.L., Huang, Y.N., Marchese, J.N., Williamson, B., Parker, K., Hattan, S., Khainovski, N., Pillai, S., Dey, S., Daniels, S., Purkayastha, S., Juhasz, P., Martin, S., Bartlet-Jones, M., He, F., Jacobson, A., and Pappin, D.J. (2004). Multiplexed protein quantitation in Saccharomyces cerevisiae using amine-reactive isobaric tagging reagents. Mol Cell Proteomics 3, 1154-1169. doi: 10.1074/mcp. M400129-MCP200.
47. Sengstock, D.M., Thyagarajan, R., Apalara, J., Mira, A., Chopra, T., and Kaye, K.S. (2010). Multidrug-resistant Acinetobacter baumannii: an emerging pathogen among older adults in community hospitals and nursing homes. Clin Infect Dis 50, 1611-1616. doi: 10.1086/652759.
48. Siroy, A., Cosette, P., Seyer, D., Lemaitre-Guillier, C., Vallenet, D., Van Dorsselaer, A., Boyer-Mariotte, S., Jouenne, T., and De, E. (2006). Global comparison of the membrane subproteomes between a multidrug-resistant Acinetobacter baumannii strain and a reference strain. J Proteome Res 5, 3385-3398. doi: 10.1021/pr060372s.
49. Soares, A.J., Santos, M.F., Trugilho, M.R., Neves-Ferreira, A.G., Perales, J., and Domont, G.B. (2009a). Differential proteomics of the plasma of individuals with sepsis caused by Acinetobacter baumannii. J Proteomics 73, 267-278. doi: 10.1016/j.jprot.2009.09.010.
50. Soares, N.C., Cabral, M.P., Gayoso, C., Mallo, S., Rodriguez-Velo, P., Fernandez-Moreira, E., and Bou, G. (2010). Associating growth-phase-related changes in the proteome of Acinetobacter baumannii with increased resistance to oxidative stress. J Proteome Res 9, 1951-1964. doi: 10.1021/pr901116r.
51. Soares, N.C., Cabral, M.P., Parreira, J.R., Gayoso, C., Barba, M.J., and Bou, G. (2009b). 2-DE analysis indicates that Acinetobacter baumannii displays a robust and versatile metabolism. Proteome Sci 7, 37. doi: 10.1186/1477-5956-7-37.
52. Soares, N.C., Spat, P., Mendez, J.A., Nakedi, K., Aranda, J., and Bou, G. (2014). Ser/Thr/Tyr phosphoproteome characterization of Acinetobacter baumannii: comparison between a reference strain and a highly invasive multidrug-resistant clinical isolate. J Proteomics 102, 113-124. doi: 10.1016/j.jprot.2014.03.009.
53. Timms, J.F., and Cramer, R. (2008). Difference gel electrophoresis. Proteomics 8, 4886-4897. doi: 10.1002/pmic.200800298.
54. Tiwari, V. (2013). Effect of Iron Availability on the Survival of Carbapenem-Resistant Acinetobacter baumannii: a Proteomic Approach. Journal of Proteomics & Bioinformatics 06. doi: 10.4172/jpb.1000270.
55. Tiwari, V. (2014). Membrane Proteomics has emerged as a Tool to Study Carbapenem Resistance in Acinetobacter baumannii. Journal of Proteomics & Bioinformatics 07. doi: 10.4172/jpb.10000e26.
56. Tiwari, V., Kapil, A., and Moganty, R.R. (2012a). Carbapenem-hydrolyzing oxacillinase in high resistant strains of Acinetobacter baumannii isolated from India. Microb Pathog 53, 81-86. doi: 10.1016/j.micpath.2012.05.004.
57. Tiwari, V., and Moganty, R.R. (2013a). Conformational stability of OXA-51 beta-lactamase explains its role in carbapenem resistance of Acinetobacter baumannii. J Biomol Struct Dyn. doi: 10.1080/07391102.2013.819789.
58. Tiwari, V., and Moganty, R.R. (2013b). Structural studies on New Delhi Metallo-beta-lactamase (NDM-2) suggest old beta-lactam, penicillin to be better antibiotic for NDM-2-harbouring Acinetobacter baumanni. J Biomol Struct Dyn 31, 591-601. doi: 10.1080/07391102.2012.706075.
59. Tiwari, V., Nagpal, I., Subbarao, N., and Moganty, R.R. (2012b). In-silico modeling of a novel OXA-51 from beta lactam-resistant Acinetobacter baumannii and its interaction with various antibiotics. J Mol Model 18, 3351-3361. doi: 10.1007/s00894-011-1346-3.
60. Tiwari, V., Vashistt, J., Kapil, A., and Moganty, R.R. (2012c). Comparative proteomics of inner membrane fraction from carbapenem-resistant Acinetobacter baumannii with a reference strain. PLoS One 7, e39451. doi: 10.1371/journal.pone.0039451.
61. Toyo'oka, T. (2012). LC-MS determination of bioactive molecules based upon stable isotope-coded derivatization method. J Pharm Biomed Anal 69, 174-184. doi: 10.1016/j.jpba.2012.04.018.
62. Unlu, M., Morgan, M.E., and Minden, J.S. (1997). Difference gel electrophoresis: a single gel method for detecting changes in protein extracts. Electrophoresis 18, 2071-2077. doi: 10.1002/elps.1150181133.
63. Vashist, J., Tiwari, V., Das, R., Kapil, A., and Rajeswari, M.R. (2011). Analysis of penicillin-binding proteins (PBPs) in carbapenem resistant Acinetobacter baumannii. Indian J Med Res 133, 332-338.
64. Vashist, J., Tiwari, V., Kapil, A., and Rajeswari, M.R. (2010). Quantitative profiling and identification of outer membrane proteins of beta-lactam resistant strain of Acinetobacter baumannii. J Proteome Res 9, 1121-1128. doi: 10.1021/pr9011188.
65. Xiaoyu, L., Weiyuan, Z., Ping, J., Anxia, W., and Liane, Z. (2013). Comparative serum proteomic analysis of adenomyosis using the isobaric tags for relative and absolute quantitation technique. Fertil Steril 100, 505-510. doi: 10.1016/j.fertnstert.2013.04.008.
66. Yan, J.X., Devenish, A.T., Wait, R., Stone, T., Lewis, S., and Fowler, S. (2002). Fluorescence two-dimensional difference gel electrophoresis and mass spectrometry based proteomic analysis of Escherichia coli. Proteomics 2, 1682-1698. doi: 10.1002/1615-9861(200212)2:12<1682::AID-PROT1682>3.0.CO;2-Y.
67. Yun, S.H., Choi, C.W., Kwon, S.O., Park, G.W., Cho, K., Kwon, K.H., Kim, J.Y., Yoo, J.S., Lee, J.C., Choi, J.S., Kim, S., and Kim, S.I. (2011). Quantitative proteomic analysis of cell wall and plasma membrane fractions from multidrug-resistant Acinetobacter baumannii. J Proteome Res 10, 459-469. doi: 10.1021/pr101012s.
68. Zhang, J., Song, M.Q., Zhu, J.S., Zhou, Z., Xu, Z.P., Chen, W.X., and Chen, N.W. (2011). Identification of differentially-expressed proteins between early submucosal non-invasive and invasive colorectal cancer using 2D-DIGE and mass spectrometry. Int J Immunopathol Pharmacol 24, 849-859.
69. Zhu, W., Smith, J.W., and Huang, C.M. (2010). Mass spectrometry-based label-free quantitative proteomics. J Biomed Biotechnol 2010, 840518. doi: 10.1155/2010/840518.